{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:38:13Z","timestamp":1790145493491,"version":"4.0.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.yexmp.2015.03.002","type":"journal-article","created":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T00:42:30Z","timestamp":1425429750000},"page":"411-418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Current perspectives of mi-RNA in oesophageal adenocarcinoma: Roles in predicting carcinogenesis, progression and values in clinical management"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9587-0644","authenticated-orcid":false,"given":"Moein","family":"Amin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2771-564X","authenticated-orcid":false,"given":"Alfred King-yin","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2015.03.002_bb0005","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ajg.2011.37","article-title":"Feasibility of mcroRNAs as biomarkers for Barrett's esophagus progression: a pilot cross-sectional, phase 2 biomarker study","volume":"106","author":"Bansal","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jcp.2005.027508","article-title":"Clinical relevance of Fas expression in oesophageal squamous cell carcinoma","volume":"59","author":"Chan","year":"2006","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0015","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.3748\/wjg.v19.i18.2772","article-title":"Oncogene GAEC1 regulates CAPN10 expression which predicts survival in oesophageal squamous cell carcinoma","volume":"19","author":"Chan","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0020","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1002\/cncr.28002","article-title":"Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma","volume":"119","author":"Chen","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.yexmp.2015.03.002_bb0025","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1245\/s10434-007-9511-8","article-title":"Altered E-cadherin expression and p120 catenin localization in oesophageal squamous cell carcinoma","volume":"14","author":"Chung","year":"2007","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0030","doi-asserted-by":"crossref","first-page":"e115589","DOI":"10.1371\/journal.pone.0115589","article-title":"MiR-145 expression accelerates esophageal adenocarcinoma progression by enhancing cell invasion and anoikis resistance","volume":"9","author":"Derouet","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.yexmp.2015.03.002_bb0035","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.yexmp.2013.12.004","article-title":"miR-126 in human cancers: clinical roles and current perspectives","volume":"96","author":"Ebrahimi","year":"2014","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0040","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1136\/jcp.2010.078253","article-title":"Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis","volume":"63","author":"Fassan","year":"2010","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0045","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/ijc.25823","article-title":"MicroRNA expression profiling in human Barrett's carcinogenesis","volume":"129","author":"Fassan","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexmp.2015.03.002_bb0050","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.humpath.2013.01.023","article-title":"The HER2-miR125a5p\/miR125b loop in gastric and esophageal carcinogenesis","volume":"44","author":"Fassan","year":"2013","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0055","first-page":"159","article-title":"Transforming capacity of two novel genes JS-1 and JS-2 located in chromosome 5p and their overexpression in human oesophageal squamous cell carcinoma","volume":"17","author":"Fatima","year":"2006","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0060","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jtcvs.2007.08.055","article-title":"MicroRNA expression profiles of esophageal cancer","volume":"135","author":"Feber","year":"2008","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0065","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.athoracsur.2011.01.056","article-title":"MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma","volume":"91","author":"Feber","year":"2011","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0070","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1007\/s10620-013-2806-7","article-title":"MicroRNA expression differentiates squamous epithelium from Barrett's esophagus and esophageal cancer","volume":"58","author":"Garman","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0075","doi-asserted-by":"crossref","first-page":"E36","DOI":"10.1002\/mc.21993","article-title":"Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance","volume":"53","author":"Gopalan","year":"2014","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0080","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.yexcr.2014.08.006","article-title":"Downregulation of microRNA-498 in colorectal cancers and its cellular effects","volume":"330","author":"Gopalan","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0085","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ijc.25330","article-title":"Prognostic significance of differentially expressed miRNAs in esophageal cancer","volume":"128","author":"Hu","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexmp.2015.03.002_bb0090","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1245\/s10434-010-1213-y","article-title":"MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma","volume":"18","author":"Hummel","year":"2011","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0095","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11605-011-1418-9","article-title":"Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells","volume":"15","author":"Hummel","year":"2011","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0100","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1053\/j.gastro.2009.02.002","article-title":"The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim","volume":"136","author":"Kan","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexmp.2015.03.002_bb0105","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.athoracsur.2012.04.145","article-title":"MicroRNA expression profiling of esophageal cancer before and after induction chemoradiotherapy","volume":"94","author":"Ko","year":"2012","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0110","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/PAT.0000000000000160","article-title":"Standardised reporting protocol for endoscopic resection for Barrett oesophagus associated neoplasia: expert consensus recommendations","volume":"46","author":"Kumarasinghe","year":"2014","journal-title":"Pathology"},{"key":"10.1016\/j.yexmp.2015.03.002_bb0115","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.humpath.2003.10.020","article-title":"Chromosomal aberrations in oesophageal squamous cell carcinoma among Chinese: gain of 12p predicts poor prognosis after surgery","volume":"35","author":"Kwong","year":"2004","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1040-8428(99)00054-2","article-title":"Critical review: molecular biology of oesophageal squamous cell carcinoma","volume":"33","author":"Lam","year":"2000","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0125","first-page":"459","article-title":"Pathology of oesophageal cancers: local experience and current insights","volume":"110","author":"Lam","year":"1997","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0130","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0959-8049(97)00094-4","article-title":"Pre-operative chemotherapy for squamous cell carcinoma of the oesophagus: do histological assessment and p53 overexpression predict chemo-responsiveness?","volume":"33","author":"Lam","year":"1997","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.yexmp.2015.03.002_bb0135","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/path.984","article-title":"Oesophageal basaloid squamous cell carcinoma: an unique clinicopathological entity with telomerase activity as a prognostic indicator","volume":"195","author":"Lam","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0140","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1038\/sj.onc.1210390","article-title":"Identification of a novel tumor transforming gene GAEC1 at 7q22 which encodes a nuclear protein and is frequently amplified and overexpressed in oesophageal squamous cell carcinoma","volume":"26","author":"Law","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.yexmp.2015.03.002_bb0145","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/gcc.21934","article-title":"The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis","volume":"51","author":"Leidner","year":"2012","journal-title":"Gene Chromosome Cancer"},{"key":"10.1016\/j.yexmp.2015.03.002_bb0150","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1746-1596-6-114","article-title":"Changes of microRNAs-192, 196a and 203 correlate with Barrett's esophagus diagnosis and its progression compared to normal healthy individuals","volume":"6","author":"Luzna","year":"2011","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0155","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00109-012-0924-x","article-title":"MicroRNA-31 modulates tumour sensitivity to radiation in oesophageal adenocarcinoma","volume":"90","author":"Lynam-Lennon","year":"2012","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.yexmp.2015.03.002_bb0160","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.yexmp.2014.08.002","article-title":"Role of microRNA-34 family in cancer with particular reference to cancer angiogenesis","volume":"97","author":"Maroof","year":"2014","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0165","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2174\/1568009614666141020100337","article-title":"MicroRNA-34 family, mechanisms of action in cancer: a review","volume":"14","author":"Maroof","year":"2014","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.yexmp.2015.03.002_bb0170","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.2353\/ajpath.2009.080718","article-title":"MicroRNA-196a is a potential marker of progression during Barrett's metaplasia\u2013dysplasia-invasive adenocarcinoma sequence in esophagus","volume":"174","author":"Maru","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0175","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1158\/1078-0432.CCR-09-1467","article-title":"MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival","volume":"15","author":"Math\u00e9","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0180","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1053\/j.gastro.2013.08.008","article-title":"Bile acids increase levels of microRNAs 221 and 222, leading to degradation of CDX2 during esophageal carcinogenesis","volume":"145","author":"Matsuzaki","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexmp.2015.03.002_bb0185","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.1158\/1078-0432.CCR-10-1110","article-title":"Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma","volume":"16","author":"Nguyen","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0190","first-page":"121","article-title":"The inhibitory effect of Gleditsia sinensis on cyclooxygenase-2 expression in human oesophageal squamous cell carcinoma","volume":"23","author":"Pak","year":"2009","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0195","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/SLA.0b013e31826ddba6","article-title":"Predictive value of MicroRNAs in the progression of Barrett esophagus to adenocarcinoma in a long-term follow-up study","volume":"257","author":"Revilla-Nuin","year":"2013","journal-title":"Ann. Surg."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0200","doi-asserted-by":"crossref","first-page":"e64463","DOI":"10.1371\/journal.pone.0064463","article-title":"Deciphering the unique microRNA signature in human esophageal adenocarcinoma","volume":"8","author":"Saad","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.yexmp.2015.03.002_bb0205","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1002\/cncr.28911","article-title":"A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma","volume":"120","author":"Skinner","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.yexmp.2015.03.002_bb0210","first-page":"1036","article-title":"miR-200 family expression is downregulated upon neoplastic progression of Barrett's esophagus","volume":"17","author":"Smith","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0215","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1158\/1078-0432.CCR-13-0601","article-title":"MicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1","volume":"19","author":"Streppel","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0220","first-page":"953","article-title":"Inhibitory effects of Gleditsia sinensis fruit extract on telomerase activity and oncogenic expression in human oesophageal squamous cell carcinoma","volume":"19","author":"Tang","year":"2007","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0225","first-page":"915","article-title":"Oncogenic properties of a novel gene JK-1 located in chromosome 5p and its overexpression in human oesophageal squamous cell carcinoma","volume":"19","author":"Tang","year":"2007","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0230","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1245\/s10434-010-0995-2","article-title":"Histological regression of squamous oesophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor","volume":"17","author":"Tong","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0235","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/gutjnl-2011-301061","article-title":"microRNA-145 in Barrett's oesophagus: regulating BMP4 signalling via GATA6","volume":"62","author":"van Baal","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.yexmp.2015.03.002_bb0240","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2174\/156800961407140926105634","article-title":"The important roles of miR-205 in normal physiology, cancers and as a potential therapeutic target","volume":"14","author":"Vosgha","year":"2014","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.yexmp.2015.03.002_bb0245","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/bjs.7000","article-title":"MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma","volume":"97","author":"Wijnhoven","year":"2010","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0250","first-page":"767","article-title":"Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma","volume":"28","author":"Wong","year":"2006","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0255","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1158\/1940-6207.CAPR-12-0276","article-title":"MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma","volume":"6","author":"Wu","year":"2013","journal-title":"Cancer. Prev. Res. (Phila.)"},{"key":"10.1016\/j.yexmp.2015.03.002_bb0260","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.1158\/1078-0432.CCR-09-0385","article-title":"MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma","volume":"15","author":"Yang","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2015.03.002_bb0265","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1007\/s11033-012-2222-7","article-title":"MiR-26a regulates cell cycle and anoikis of human esophageal adenocarcinoma cells through Rb1-E2F1 signaling pathway","volume":"40","author":"Zhang","year":"2013","journal-title":"Mol. Biol. Rep."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480015000295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480015000295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T13:56:24Z","timestamp":1537797384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480015000295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0014480015000295"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2015.03.002","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current perspectives of mi-RNA in oesophageal adenocarcinoma: Roles in predicting carcinogenesis, progression and values in clinical management","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2015.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}